Figure 6.
Stable transfection of DN caspase-9 diminishes Bay 11-7082/UCN-01-induced apoptosis in MM cells. U266 cells were stably transfected with a DN caspase-9 (mutation of cysteine to alanine at the active residue 286) or an empty vector (pcDNA3.1), as described in “Materials and methods.” Transfected cells were treated with 4 μM Bay 11-7082 + 200 nM UCN-01 for 24 hours, after which the extent of apoptosis was monitored by annexin V-FITC staining and flow cytometric analysis as described for Figure 1C; results are representative of 3 separate experiments (A). Cells were treated as described for panel A, and the percentage of cells displaying morphologic evidence of apoptosis or loss of mitochondrial membrane potential (Δψm) was determined as described in “Materials and methods.” Values represent means ± SD for 3 separate experiments performed in triplicate. **Significantly lower than values for cells transfected with empty vector; P < .002 (B). Alternatively, Western blot analysis was used to monitor the expression/cleavage of the indicated caspases and PARP, the release of cytochrome c and Smac/DIABLO into the cytosolic S-100 fraction (C) or the phosphorylation of IκBα, JNK, and p34cdc2, and the expression of antiapoptotic proteins (D). (C-D) Each lane was loaded with 30 μg protein; blots were subsequently reprobed for actin expression to ensure equivalent loading and transfer of protein. CF indicates cleavage fragment. Results of a representative experiment are shown; an additional study yielded equivalent results.